secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLOBUS MEDICAL INC (GMED)
CIK:        0001237831
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0001562762-25-000114
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Globus Medical Q1 revenue down 1.4% to $598.1M; cuts non-GAAP EPS guidance to $3.00-$3.30
--------------------------------------------------------------------------------

- GAAP net income $75.5M; GAAP diluted EPS $0.54 vs ($0.05) a year ago.
- Non-GAAP diluted EPS $0.68, up 8.5% YoY; prior guidance $3.10-$3.40 now $3.00-$3.30.
- Revenue fell 1.4% as-reported (0.8% constant currency); US up 0.2%, Intl down 7.7% as-reported.
- Paid off remaining $450M debt from NuVasive merger; Q1 free cash flow $141.2M.
- Company cites softer Enabling Technology deals, supply chain disruption, and timing of intl orders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1237831/000156276225000114/0001562762-25-000114-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1237831/000156276225000114/gmed-20250508x8k.htm
  HTML page:      https://secwatch.observer/filing/0001562762-25-000114

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer